Late breaking abstracts: Prostate and bladder cancer
LB99 – LB106
- LB99: Aspirin, non-steroidal anti-inflammatory drug and paracetamol use is associated with an increased risk of prostate cancer in a large, population-based, case-control study
- LB100: Lifestyle intervention improves functional capacity in men on androgen deprivation therapy for prostate cancer
- LB101: Plasma phytanic acid concentration and risk of prostate cancer
- LB102: Investigating the link between diet and prostate cancer within the ProtecT trial
- LB103: A comparison of the UCLA Integrated Staging System (UISS) model and the Leibovich score in survival prediction for patients with non-metastatic clear cell renal cell carcinoma
- LB104: A neurofuzzy model to identify insignificant prostate cancer: development and validation using the ProtecT randomised controlled trial
- LB105: A comparison of MicroRNA profiles in the circulating cells from men with locally confined and advanced prostate cancer
- LB106: Epigenetic regulation of MicroRNA in bladder cancer
